XML 17 R28.htm IDEA: XBRL DOCUMENT v3.20.1
Employee Benefit Plans (Tables)
3 Months Ended
Mar. 29, 2020
Employee Benefits And Share Based Compensation [Abstract]  
Schedule of Stock Option Activity

Stock option activity during the three months ended March 29, 2020 was as follows:

 

 

 

Number of

Shares

 

 

Weighted Average Exercise Price Per Share

 

 

 

(In thousands)

 

 

(In dollars)

 

Outstanding as of December 31, 2019

 

 

2,188

 

 

$

26.03

 

Exercised

 

 

(22

)

 

$

20.87

 

Expired

 

 

(3

)

 

$

22.07

 

Outstanding as of March 29, 2020

 

 

2,163

 

 

$

26.09

 

Schedule of RSU Activity

RSU activity during the three months ended March 29, 2020 was as follows:

 

 

 

Number

of Shares

 

 

Weighted Average Grant Date Fair Value Per Share

 

 

 

(In thousands)

 

 

(In dollars)

 

Outstanding as of December 31, 2019

 

 

1,587

 

 

$

33.95

 

Granted

 

 

40

 

 

$

26.08

 

Vested

 

 

(151

)

 

$

40.20

 

Cancelled

 

 

(17

)

 

$

36.02

 

Outstanding as of March 29, 2020

 

 

1,459

 

 

$

33.07

 

Schedule of Weighted Average Assumptions The following table sets forth the weighted average assumptions used to estimate the fair value of purchase rights granted under the ESPP during the three months ended March 29, 2020 and March 31, 2019:

 

 

 

Three Months Ended

 

 

 

March 29,

2020

 

 

March 31,

2019

 

 

 

ESPP

 

Expected life (in years)

 

 

0.5

 

 

 

0.5

 

Risk-free interest rate

 

 

1.55

%

 

 

2.49

%

Expected volatility

 

 

38.8

%

 

 

42.6

%

Dividend yield

 

 

 

 

 

 

 

Schedule of Total Stock-Based Compensation Expense Resulting from Stock Options, RSUs, and the ESPP

The following table sets forth the stock-based compensation expense resulting from stock options, RSUs and the ESPP included in the Company’s unaudited condensed consolidated statements of operations:

 

 

 

Three Months Ended

 

 

 

March 29,

2020

 

 

March 31,

2019

 

 

 

(In thousands)

 

Cost of revenue

 

$

705

 

 

$

668

 

Research and development

 

 

1,034

 

 

 

1,192

 

Sales and marketing

 

 

1,779

 

 

 

2,041

 

General and administrative

 

 

2,818

 

 

 

2,557

 

Total

 

$

6,336

 

 

$

6,458